Consumer Inertia and Firm Pricing in the Medicare Part D Prescription Drug Insurance Exchange
- (pp. 38-64)
Abstract
I use the Medicare Part D prescription drug insurance market to examine the dynamics of firm interaction with consumers on an insurance exchange. Enrollment data show that consumers face switching frictions leading to inertia in plan choice, and a regression discontinuity design indicates initial defaults have persistent effects. In the absence of commitment to future prices, theory predicts firms respond to inertia by raising prices on existing enrollees, while introducing cheaper alternative plans. The complete set of enrollment and price data from 2006 through 2010 confirms this prediction: older plans have approximately 10 percent higher premiums than comparable new plans.Citation
Marzilli Ericson, Keith M. 2014. "Consumer Inertia and Firm Pricing in the Medicare Part D Prescription Drug Insurance Exchange." American Economic Journal: Economic Policy, 6 (1): 38-64. DOI: 10.1257/pol.6.1.38Additional Materials
JEL Classification
- G22 Insurance; Insurance Companies; Actuarial Studies
- I13 Health Insurance, Public and Private
- I18 Health: Government Policy; Regulation; Public Health
- L11 Production, Pricing, and Market Structure; Size Distribution of Firms
- L65 Chemicals; Rubber; Drugs; Biotechnology
There are no comments for this article.
Login to Comment